Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter RCT to Evaluate the Clinical and Cost-effectiveness of a Culturally Adapted Therapy (C-MAP) in Patients With a History of Self-harm

NCT02742922 is registered in ClinicalTrials.gov with Pakistan Institute of Living and Learning as lead sponsor.

NCT NCT02742922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02742922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter RCT to Evaluate the Clinical and Cost-effectiveness of a Culturally Adapted Therapy (C-MAP) in Patients With a History of Self-harm
Lead sponsor
Pakistan Institute of Living and Learning
Phase
Not applicable
Overall status
Completed
Start date
April 27, 2016
Completion date
October 30, 2019
Enrollment
901 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

self harm